27-09-2024 |
AH |
|
BLUE |
bluebird bio |
93.00 |
-0.42 |
-0.40 |
0.00 |
|
0.5212 |
0.02 (3.33%) |
0.52 |
0.01 (2.87%) |
0.46 - 5.53 |
6,008,754 |
8,360,000 |
117,722 |
|
|
09-05-2024 |
PM |
|
BLUE |
bluebird bio, Inc. |
110.43 |
N/A |
-0.47 |
0.21 |
bluebird bio reports Q1 results [5/9/2024 7:03 AM] |
1.12 |
0.15 (14.92%) |
1.02 |
0.05 (4.66%) |
0.85 - 5.53 |
10,597,781 |
8,210,000 |
243,795 |
|
|
07-11-2023 |
PM |
|
BLUE |
bluebird bio, Inc. |
372.20 |
-0.66 |
-0.69 |
-0.92 |
bluebird bio GAAP EPS of -$0.66 beats by $0.01, revenue of $12.39M misses by $1.02M [11/7/2023 7:01 AM] |
3.54 |
0.24 (7.27%) |
3.45 |
0.15 (4.55%) |
2.52 - 8.58 |
4,948,277 |
3,790,000 |
11,721 |
|
|
08-08-2023 |
PM |
|
BLUE |
bluebird bio, Inc. |
412.88 |
-0.67 |
-0.72 |
-1.29 |
bluebird bio GAAP EPS of -$0.67 beats by $0.04, revenue of $6.89M misses by $4.36M [8/8/2023 7:03 AM] |
3.90 |
0.30 (8.47%) |
3.60 |
0.0 (0.00%) |
2.78 - 8.58 |
10,521,274 |
3,460,000 |
60,618 |
|
|
09-05-2023 |
PM |
7:00 AM ET (May 9) |
BLUE |
bluebird bio, Inc. |
464.84 |
0.21 |
-0.54 |
-1.66 |
bluebird bio GAAP EPS of $0.21 beats by $0.52, revenue of $2.38B beats by $2.35B [5/9/2023 7:05 AM] |
4.92 |
0.57 (12.99%) |
4.11 |
-0.24 (-5.52%) |
2.78 - 8.58 |
4,871,976 |
4,520,000 |
39,640 |
|
|
29-03-2023 |
PM |
7:00 AM ET (Mar 29) |
BLUE |
bluebird bio |
367.00 |
-0.57 |
-0.45 |
0.00 |
bluebird bio GAAP EPS of -$0.38 misses by $0.18, revenue of $0.06M misses by $15.34M [3/29/2023 7:04 AM] |
3.15 |
-1.17 (-27.08%) |
3.66 |
-0.66 (-15.28%) |
2.87 - 8.58 |
18,230,140 |
4,480,000 |
298,541 |
|
|
04-08-2022 |
AH |
4:05 PM ET (Aug 4) |
BLUE |
bluebird bio |
289.00 |
-1.29 |
-1.31 |
0.00 |
bluebird bio GAAP EPS of -$1.36 misses by $0.07, revenue of $1.52M beats by $0.81M [8/4/2022 5:23 PM] |
5.57 |
0.99 (21.62%) |
4.57 |
-0.01 (-0.22%) |
2.87 - 17.85 |
22,359,007 |
4,670,000 |
74,218 |
|
|
09-05-2022 |
AH |
4:30 PM ET (May 9) |
BLUE |
bluebird bio |
290.00 |
-1.66 |
-1.26 |
0.00 |
bluebird bio GAAP EPS of -$1.66 misses by $0.30, revenue of $1.95M beats by $1.78M [5/9/2022 5:13 PM] |
3.82 |
0.48 (14.56%) |
3.43 |
0.10 (3.00%) |
3.30 - 23.05 |
2,278,681 |
2,282,483 |
3,453 |
|
|
04-03-2022 |
AH |
|
BLUE |
bluebird bio |
388.00 |
-1.82 |
-1.82 |
0.00 |
bluebird bio GAAP EPS of -$1.83 misses by $0.07, revenue of $1.61M misses by $4.11M [3/4/2022 4:33 PM] |
4.34 |
-0.65 (-13.10%) |
4.30 |
-0.70 (-14.00%) |
4.16 - 23.04 |
2,821,536 |
1,700,000 |
183,403 |
|
|
05-11-2021 |
PM |
|
BLUE |
bluebird bio |
1,678 |
-2.93 |
-2.72 |
0.00 |
bluebird bio EPS misses by $0.51, misses on revenue [11/5/2021 7:56 AM] |
13.17 |
-3.14 (-19.23%) |
17.75 |
1.44 (8.85%) |
11.10 - 34.75 |
5,663,962 |
890,000 |
58,503 |
|
|
09-08-2021 |
PM |
7:00 AM ET (Aug 9) |
BLUE |
Bluebird Bio, Inc. |
1,745 |
-3.58 |
-3.26 |
0.00 |
bluebird bio EPS misses by $0.32, misses on revenue [8/9/2021 7:02 AM] |
18.15 |
-6.88 (-27.49%) |
19.40 |
-5.63 (-22.49%) |
18.11 - 66.12 |
8,665,068 |
820,000 |
403,598 |
|
|
05-05-2021 |
AH |
|
BLUE |
Bluebird Bio, Inc. |
1,996 |
-3.07 |
-3.05 |
0.00 |
bluebird bio EPS misses by $0.08, beats on revenue [5/5/2021 4:59 PM] |
29.68 |
0.47 (1.61%) |
29.21 |
0.0 (0.00%) |
24.24 - 72.50 |
1,036,062 |
870,000 |
1,975 |
|
|
23-02-2021 |
AH |
|
BLUE |
bluebird bio, Inc. |
1,770 |
-3.01 |
-3.02 |
-4.04 |
bluebird bio EPS misses by $0.05, misses on revenue [2/23/2021 4:56 PM] |
25.93 |
0.31 (1.21%) |
26.22 |
0.60 (2.34%) |
24.24 - 77.68 |
3,216,294 |
4,392,859 |
33,515 |
|
-
bluebird bio EPS misses by $0.05, misses on revenue [2/23/2021 4:56 PM]
-
bluebird bio earnings show high cash burn as FDA turns LentiGlobin suspension into a hold [2/23/2021 6:03 PM]
-
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BLUE, TCDA and JFU [Feb-24-21 02:30PM]
-
BLUE SHAREHOLDER FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Has Been Filed Against bluebird bio, Inc. [Feb-24-21 01:19PM]
-
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against bluebird bio, Inc. (BLUE) [Feb-24-21 12:00PM]
-
BLUE Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds bluebird bio, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm [Feb-24-21 11:00AM]
-
Is There Any Hope for bluebird bio Stock? [Feb-24-21 06:56AM]
-
CLASS ACTION UPDATE for BLUE, BTBT and CLOV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [Feb-23-21 06:33PM]
-
bluebird bio Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Operational Progress [Feb-23-21 04:05PM]
-
LAWSUITS FILED AGAINST BLUE, XOM and EH - Jakubowitz Law Pursues Shareholders Claims [Feb-23-21 03:20PM]
-
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Feb-23-21 02:39PM]
-
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BLUE, IRTC and FUBO [Feb-23-21 01:37PM]
-
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against bluebird bio, Inc. (BLUE) [Feb-23-21 12:30PM]
-
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BLUE, BTBT and XOM [Feb-23-21 12:00PM]
-
SHAREHOLDER DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Feb-23-21 11:15AM]
-
bluebird bio: Positive Resolution Of Clinical Hold Could Drive Asymmetrical Upside [Feb-23-21 05:38AM]
|
04-11-2020 |
AH |
|
BLUE |
bluebird bio, Inc. |
3,610 |
-2.94 |
-3.07 |
-3.73 |
bluebird bio EPS beats by $0.08, misses on revenue [11/4/2020 5:07 PM] |
48.73 |
-9.82 (-16.77%) |
48.46 |
-10.09 (-17.23%) |
38.95 - 99.36 |
7,219,848 |
673,392 |
104,425 |
|
|
05-08-2020 |
AH |
|
BLUE |
bluebird bio, Inc. |
3,490 |
-0.36 |
-1.91 |
-3.55 |
bluebird bio EPS beats by $2.16, beats on revenue [8/5/2020 5:02 PM] |
63.84 |
0.0 (0.00%) |
64.00 |
0.16 (0.25%) |
38.95 - 126.39 |
236,377 |
779,608 |
441 |
|
|